Cancer, Lung Clinical Trial
Official title:
Effects of Transcutaneous Electrical Nerve Stimulation in the Conventional Mode in Post-operative Lung Cancer Patients in a Reference Hospital in the Amazon Region
Among all cancers, lung cancer is the most common disease on the planet, accounting for 13%
of the cases, and leading the number of deaths from malignant diseases. In Brazil, it is
estimated that its incidence between 2018 and 2019 could be 18,704 new cases in men and
12,503,000 new cases in women. These data take into account an estimated risk of 18.16 new
cases for 100,000 men and 11.81 for 100,000 women, respectively occupying the second and
fourth most frequent cases of the disease according to gender .
Surgeries, however aggressive they may be, are one of the most viable alternatives for
patients with PC, provided it is performed in the milder or early phase of the disease, since
after such period this procedure may have a period degree greater than the other forms of
treatment.
As a consequence, the injuries that the surgical procedure can cause to patients, pain is one
of the most influential in the patient's quality of life. It can lead the individual to a
marked state of disability both functional and psychological, thus being determinant for the
suffering related to the disease, thus comprising its multifactorial character, involving
physical, emotional, socio-cultural and environmental aspects .
For the control of pain, physiotherapy appears with features such as transcutaneous nerve
electrostimulation, where its use for the suppression of pain has become quite feasible due
mainly to the ease of its handling, to be noninvasive and to serve to reduce acute pain and
chronic.
The use of conventional transcutaneous nerve electrostimulation to support the use of
analgesics reduced the intensity of pain in patients of the second day of thoracotomy, but
for a longer extension of their effects, it would take a longer time to apply the resource,
something around 24 -48 hours.
n/a
| Status | Clinical Trial | Phase | |
|---|---|---|---|
| Recruiting |
NCT06152419 -
Patient Education Videos to Improve Patients' Experience During Radiotherapy Treatment: a National Project
|
N/A | |
| Recruiting |
NCT04105647 -
Lifestyle Modification Program for Lung Cancer Patients - A Pilot Study
|
N/A | |
| Completed |
NCT05732350 -
Exploratory Drug Interaction Study Between SMIs and DOACs
|
||
| Active, not recruiting |
NCT04300244 -
Nivolumab and Ipilimumab +/- UV1 Vaccination as Second Line Treatment in Patients With Malignant Mesothelioma
|
Phase 2 | |
| Recruiting |
NCT05311709 -
Sotorasib in Advanced KRASG12C-mutated Non-small Cell Lung Cancer Patients With Comorbidities
|
Phase 2 | |
| Active, not recruiting |
NCT04396457 -
Pembrolizumab Plus Pemetrexed for Elderly Patients With Non-Sq NSCLC With PD-L1 < 50%: CJLSG1901
|
Phase 2 | |
| Not yet recruiting |
NCT03910283 -
Leveraging Mindsets to Improve Health & Wellbeing in Patients With Cancer
|
N/A | |
| Recruiting |
NCT03301493 -
Genomic Testing and Resulting Medical Decisions
|
||
| Completed |
NCT04788147 -
Performance and Safety of Biology-Guided Radiotherapy Using the RefleXion Medical Radiotherapy System (BIOGUIDE-X)
|
N/A | |
| Not yet recruiting |
NCT06035731 -
Evaluation of the Medical Service by Socio-aesthetics in Oncology
|
N/A | |
| Recruiting |
NCT03274349 -
Whole Body Electromyostimulation and Nutritional Therapy for Patients With Esophageal and Bronchial Carcinoma
|
N/A | |
| Recruiting |
NCT05830097 -
A Study of Bi-Ligand-Drug Conjugate CBP-1019 in Patients With Advanced Solid Tumors
|
Phase 1/Phase 2 | |
| Active, not recruiting |
NCT02991677 -
Exercise Effect on Chemotherapy-Induced Neuropathic Pain
|
N/A | |
| Completed |
NCT04971304 -
Comparative Effectiveness Analysis of Granulocyte Colony Stimulating Factor Originator Products Versus Biosimilars
|
||
| Recruiting |
NCT04859400 -
Influence of a Home-based Nutrition and Exercise Program on Quality of Life of Palliative Cancer Outpatients
|
N/A | |
| Recruiting |
NCT05948865 -
A Phase 1 Study of CPO301 in Adult Patients With Advanced or Metastatic Solid Tumors
|
Phase 1 | |
| Recruiting |
NCT04270890 -
Investigation of an Abdominal Compression Device
|
N/A | |
| Not yet recruiting |
NCT05154474 -
Assessment of Sarcopenia at Diagnosis for Patients With Previously Untreated Metastatic Cancer or Hematologic Malignancy
|
||
| Not yet recruiting |
NCT05857995 -
Precision Lung Cancer Survivorship Care Intervention
|
N/A | |
| Not yet recruiting |
NCT03622528 -
Quantitative Lung Cancer Screening
|